Literature DB >> 8426121

Interferon gamma inhibits interleukin 10 production by monocytes.

P Chomarat1, M C Rissoan, J Banchereau, P Miossec.   

Abstract

Interleukin 10 (IL-10) was first described for its ability to inhibit interferon gamma (IFN-gamma) production. Herein, we studied the balance between IFN-gamma and IL-10 production by human peripheral blood mononuclear cells (PBMC) in response to Staphylococcus aureus Cowan (SAC) or lipopolysaccharide (LPS). Monocyte depletion reduced IL-10 production by 90% and resulted in an increased IFN-gamma production. Addition of anti-IL-10 antibody to PBMC cultures also strongly increased IFN-gamma production. In contrast, among various cytokines, only IFN-gamma strongly reduced IL-10 synthesis by SAC- or LPS-activated PBMC and monocytes. Thus, IFN-gamma has proinflammatory effects through the combination of two mechanisms: (a) induction of early tumor necrosis factor alpha (TNF-alpha) and IL-1 beta synthesis; and (b) inhibition of the delayed production of IL-10, an inhibitor of TNF-alpha and IL-1 beta synthesis. Taken together, the present data indicate that IFN-gamma and IL-10 antagonize each other's production and function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426121      PMCID: PMC2190918          DOI: 10.1084/jem.177.2.523

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Interleukin-1 induces interleukin-6 production in peripheral blood monocytes.

Authors:  G Tosato; K D Jones
Journal:  Blood       Date:  1990-03-15       Impact factor: 22.113

3.  Epitope mapping of recombinant human gamma interferon using monoclonal antibodies.

Authors:  C Favre; J Wijdenes; H Cabrillat; O Djossou; J Banchereau; J E de Vries
Journal:  Mol Immunol       Date:  1989-01       Impact factor: 4.407

4.  Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes.

Authors:  A A te Velde; R J Huijbens; K Heije; J E de Vries; C G Figdor
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

5.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Authors:  C C Czerkinsky; L A Nilsson; H Nygren; O Ouchterlony; A Tarkowski
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor.

Authors:  S D Sisson; C A Dinarello
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

7.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

8.  Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.

Authors:  P H Hart; G A Whitty; D S Piccoli; J A Hamilton
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  64 in total

1.  Interleukin 10 treatment for rheumatoid arthritis.

Authors:  E W St Clair
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

4.  Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge.

Authors:  Christopher H Logue; Aaron T Phillips; Eric C Mossel; Jeremy P Ledermann; Thomas Welte; Steve W Dow; Ken E Olson; Ann M Powers
Journal:  Antiviral Res       Date:  2010-05-07       Impact factor: 5.970

5.  Inflammation and mortality in a frail mouse model.

Authors:  Fred Ko; Qilu Yu; Qian-Li Xue; Wenliang Yao; Cory Brayton; Huanle Yang; Neal Fedarko; Jeremy Walston
Journal:  Age (Dordr)       Date:  2011-06-02

6.  Lack of TNF-α-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages.

Authors:  Eleni A Skokos; Antonios Charokopos; Khadija Khan; Jackie Wanjala; Themis R Kyriakides
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

7.  Mycobacterial glycolipid cord factor trehalose 6,6'-dimycolate causes a decrease in serum cortisol during the granulomatous response.

Authors:  Jeffrey K Actor; Jessica Indrigo; Christopher M Beachdel; Margaret Olsen; Alice Wells; Robert L Hunter; Amitava Dasgupta
Journal:  Neuroimmunomodulation       Date:  2002 -2003       Impact factor: 2.492

8.  Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression.

Authors:  Guillaume Page; Arne Sattler; Sabine Kersten; Andreas Thiel; Andreas Radbruch; Pierre Miossec
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

9.  Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis.

Authors:  S A Fulton; J M Johnsen; S F Wolf; D S Sieburth; W H Boom
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 10.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.